Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedMay 22, 2026
DataAggregated Company Financials
Companies5
  • 7D-3.2%
  • 3M-11.2%
  • 1Y-4.3%
  • YTD-0.9%

Over the last 7 days, the Pharma industry has dropped 3.2%, driven by Duopharma Biotech Berhad declining 3.8%. Overall the industry is down 4.3% in 12 months. Looking forward, earnings are forecast to grow by 4.5% annually.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 22 May 2026RM 2.3bRM 1.9bRM 170.8m13.2x13.5x1.2x
Sun, 19 Apr 2026RM 2.3bRM 1.9bRM 169.4m14.2x13.8x1.2x
Tue, 17 Mar 2026RM 2.4bRM 1.9bRM 169.4m14.2x14.2x1.3x
Thu, 12 Feb 2026RM 2.5bRM 1.9bRM 165.6m14.3x15.2x1.3x
Sat, 10 Jan 2026RM 4.3bRM 2.8bRM 231.9m14.7x18.4x1.5x
Mon, 08 Dec 2025RM 4.2bRM 2.8bRM 231.9m14.5x18.1x1.5x
Wed, 05 Nov 2025RM 4.2bRM 2.8bRM 223.3m15.3x18.9x1.5x
Fri, 03 Oct 2025RM 4.2bRM 2.8bRM 223.3m15.8x18.7x1.5x
Sun, 31 Aug 2025RM 4.3bRM 2.8bRM 224.6m15.9x18.9x1.5x
Tue, 29 Jul 2025RM 4.3bRM 2.8bRM 230.3m15.9x18.5x1.5x
Thu, 26 Jun 2025RM 4.1bRM 2.8bRM 230.3m15.9x17.7x1.4x
Sat, 24 May 2025RM 4.0bRM 2.8bRM 233.0m15.4x17x1.4x
Mon, 21 Apr 2025RM 3.7bRM 2.8bRM 221.0m16.4x16.7x1.3x
Wed, 19 Mar 2025RM 3.7bRM 2.8bRM 221.0m16.3x16.8x1.3x
Fri, 14 Feb 2025RM 4.1bRM 2.7bRM 223.9m17.4x18.5x1.5x
Sun, 12 Jan 2025RM 4.1bRM 2.7bRM 223.9m17.7x18.4x1.5x
Tue, 10 Dec 2024RM 4.2bRM 2.7bRM 223.9m16.5x18.8x1.5x
Thu, 07 Nov 2024RM 4.3bRM 2.7bRM 230.0m14x18.6x1.6x
Sat, 05 Oct 2024RM 4.5bRM 2.7bRM 230.0m14.5x19.4x1.7x
Mon, 02 Sep 2024RM 4.3bRM 2.7bRM 230.0m14.6x18.7x1.6x
Wed, 31 Jul 2024RM 4.4bRM 2.6bRM 541.3m12.8x8.1x1.7x
Fri, 28 Jun 2024RM 4.5bRM 2.6bRM 541.3m13.1x8.3x1.7x
Sun, 26 May 2024RM 4.5bRM 2.6bRM 541.4m13.5x8.3x1.7x
Tue, 23 Apr 2024RM 4.5bRM 2.6bRM 559.3m12.2x8x1.7x
Thu, 21 Mar 2024RM 4.5bRM 2.6bRM 559.3m12.3x8.1x1.7x
Sat, 17 Feb 2024RM 4.7bRM 2.6bRM 584.9m12.3x8x1.8x
Mon, 15 Jan 2024RM 4.3bRM 2.6bRM 584.9m12.4x7.4x1.7x
Wed, 13 Dec 2023RM 4.1bRM 2.6bRM 584.9m12x7x1.6x
Fri, 10 Nov 2023RM 4.2bRM 2.6bRM 597.0m12.1x7.1x1.6x
Sun, 08 Oct 2023RM 4.2bRM 2.6bRM 604.4m12.2x7x1.6x
Tue, 05 Sep 2023RM 4.2bRM 2.6bRM 604.4m12.4x7x1.6x
Thu, 03 Aug 2023RM 4.4bRM 2.6bRM 304.7m14.2x14.4x1.7x
Sat, 01 Jul 2023RM 4.2bRM 2.6bRM 304.7m14.1x13.9x1.7x
Mon, 29 May 2023RM 4.7bRM 2.6bRM 305.1m13.6x15.3x1.8x
Price to Earnings Ratio

15.3x


Total Market Cap: RM 4.7bTotal Earnings: RM 305.1mTotal Revenue: RM 2.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 14x202420252026
Current Industry PE
  • Investors are relatively neutral on the Malaysian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 14.0x.
  • The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 1.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 18% per year over the last three years,
  • Revenues have also declined 10% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the Malaysian Healthcare industry?

MY Market-1.84%
Healthcare-1.74%
Pharma-3.21%
Pharma-3.21%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RHONEMA Rhone Ma Holdings BerhadRM 0.690.7%
+RM 1.1m		9.4%PE10.8x

Latest News

KOTRA
RM 3.82
Kotra Industries Berhad
7D
-4.5%
1Y
-7.1%
DPHARMA
RM 1.27
Duopharma Biotech Berhad
7D
-3.8%
1Y
-2.3%
YSPSAH
RM 2.11
Y.S.P. Southeast Asia Holding Berhad
7D
-0.9%
1Y
-6.6%
RHONEMA
RM 0.69
Rhone Ma Holdings Berhad
7D
0.7%
1Y
9.4%